BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33046048
Number of visits today
811
Number of downloads
16241658
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Xu Z, Chen X, Song L, Yuan F, Yan Y. Matrix Remodeling-Associated Protein 8 as a Novel Indicator Contributing to Glioma Immune Response by Regulating Ferroptosis. Front Immunol 2022;13:834595. [PMID: 35281049 DOI: 10.3389/fimmu.2022.834595] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Tan L, Fu D, Liu F, Liu J, Zhang Y, Li X, Gao J, Tao K, Wang G, Wang L, Wang Z. MXRA8 is an immune-relative prognostic biomarker associated with metastasis and CD8(+) T cell infiltration in colorectal cancer. Front Oncol 2022;12:1094612. [PMID: 36703779 DOI: 10.3389/fonc.2022.1094612] [Reference Citation Analysis]
2 Zhou X, Sheikh AM, Matsumoto KI, Mitaki S, Shibly AZ, Zhang Y, A G, Yano S, Nagai A. iTRAQ-Based Proteomic Analysis of APP Transgenic Mouse Urine Exosomes. Int J Mol Sci 2022;24. [PMID: 36614115 DOI: 10.3390/ijms24010672] [Reference Citation Analysis]
3 Zhang G, Fang Y, Li X, Zhang Z. Ferroptosis: A novel therapeutic strategy and mechanism of action in glioma. Front Oncol 2022;12:947530. [DOI: 10.3389/fonc.2022.947530] [Reference Citation Analysis]
4 Cheng K, Guo Q, Shen Z, Yang W, Zhou Y, Sun Z, Yao X, Wu H. Frontiers of ferroptosis research: An analysis from the top 100 most influential articles in the field. Front Oncol 2022;12:948389. [DOI: 10.3389/fonc.2022.948389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Gao X, Zhao J, Jia L, Zhang Q. Remarkable immune and clinical value of novel ferroptosis-related genes in glioma. Sci Rep 2022;12:12854. [PMID: 35896732 DOI: 10.1038/s41598-022-17308-7] [Reference Citation Analysis]
6 Song L, Wu J, Fu H, Wu C, Tong X, Zhang M. Abnormally Expressed Ferroptosis-Associated FANCD2 in Mediating the Temozolomide Resistance and Immune Response in Glioblastoma. Front Pharmacol 2022;13:921963. [PMID: 35754466 DOI: 10.3389/fphar.2022.921963] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345